Cargando…

Genetics of Warfarin Sensitivity in an Emergency Department Population with Thromboembolic

BACKGROUND: Emergency department (ED) patients with venous thromboembolism (VTE) are eventually treated with a standard dose of warfarin despite the fact that a number of patients are known to be sensitive to warfarin and may experience supra-therapeutic INRs and adverse bleeding events. Pharmacogen...

Descripción completa

Detalles Bibliográficos
Autores principales: Johnson, Sara W., Henderson, Sean
Formato: Texto
Lenguaje:English
Publicado: Department of Emergency Medicine, University of California, Irvine School of Medicine 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3088368/
https://www.ncbi.nlm.nih.gov/pubmed/21691466
_version_ 1782202879323406336
author Johnson, Sara W.
Henderson, Sean
author_facet Johnson, Sara W.
Henderson, Sean
author_sort Johnson, Sara W.
collection PubMed
description BACKGROUND: Emergency department (ED) patients with venous thromboembolism (VTE) are eventually treated with a standard dose of warfarin despite the fact that a number of patients are known to be sensitive to warfarin and may experience supra-therapeutic INRs and adverse bleeding events. Pharmacogenetics is an emerging field of medical practice that seeks to improve drug safety and efficacy in an individual patient by tailoring treatment to the patient’s known genetic makeup. OBJECTIVE: To identify patients with risk for warfarin sensitivity among an ED population with VTE and to assess if the warfarin sensitivity mutations were of significant enough prevalence to be of clinical significance in customizing treatment of VTE. We sought in a pilot study to identify if testing for common CYP2C9 and VKORC1 single nucleotide polymorphisms (SNPs) in patients who were likely to begin warfarin treatment was feasible in an ED setting. METHODS: A prospective study that identified and enrolled patients presenting to our ED with high clinical suspicion of VTE. Those with high clinical suspicion of VTE were defined as those who had a Doppler ultrasound or computed tomography pulmonary angiography (CTPA) ordered by the primary emergency physician. Blood was taken and processed to ascertain the following SNPs: CYP2C9*2, CYP2C9*3, and VKORC1 3673. RESULTS: Of the 194 patients enrolled, 132 (68.0%) had at least one known warfarin sensitivity mutation and 114 (58.8%) had the most clinically significant VKORC1 3673 mutation. CONCLUSION: A majority of our patients had at least one mutation associated with the atypical metabolism of warfarin. Over half of our population had the most clinically significant VKORC1 3673 mutation. They would likely benefit from individualized warfarin dosing if ever needing anticoagulation. Our initial pilot study shows that allele frequencies of target warfarin sensitivity SNPs in our patient population are frequent enough to make initiation of personalized warfarin dosing feasible.
format Text
id pubmed-3088368
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher Department of Emergency Medicine, University of California, Irvine School of Medicine
record_format MEDLINE/PubMed
spelling pubmed-30883682011-06-20 Genetics of Warfarin Sensitivity in an Emergency Department Population with Thromboembolic Johnson, Sara W. Henderson, Sean West J Emerg Med Clinical Practice BACKGROUND: Emergency department (ED) patients with venous thromboembolism (VTE) are eventually treated with a standard dose of warfarin despite the fact that a number of patients are known to be sensitive to warfarin and may experience supra-therapeutic INRs and adverse bleeding events. Pharmacogenetics is an emerging field of medical practice that seeks to improve drug safety and efficacy in an individual patient by tailoring treatment to the patient’s known genetic makeup. OBJECTIVE: To identify patients with risk for warfarin sensitivity among an ED population with VTE and to assess if the warfarin sensitivity mutations were of significant enough prevalence to be of clinical significance in customizing treatment of VTE. We sought in a pilot study to identify if testing for common CYP2C9 and VKORC1 single nucleotide polymorphisms (SNPs) in patients who were likely to begin warfarin treatment was feasible in an ED setting. METHODS: A prospective study that identified and enrolled patients presenting to our ED with high clinical suspicion of VTE. Those with high clinical suspicion of VTE were defined as those who had a Doppler ultrasound or computed tomography pulmonary angiography (CTPA) ordered by the primary emergency physician. Blood was taken and processed to ascertain the following SNPs: CYP2C9*2, CYP2C9*3, and VKORC1 3673. RESULTS: Of the 194 patients enrolled, 132 (68.0%) had at least one known warfarin sensitivity mutation and 114 (58.8%) had the most clinically significant VKORC1 3673 mutation. CONCLUSION: A majority of our patients had at least one mutation associated with the atypical metabolism of warfarin. Over half of our population had the most clinically significant VKORC1 3673 mutation. They would likely benefit from individualized warfarin dosing if ever needing anticoagulation. Our initial pilot study shows that allele frequencies of target warfarin sensitivity SNPs in our patient population are frequent enough to make initiation of personalized warfarin dosing feasible. Department of Emergency Medicine, University of California, Irvine School of Medicine 2011-02 /pmc/articles/PMC3088368/ /pubmed/21691466 Text en Copyright © 2011 the authors. http://creativecommons.org/licenses/by-nc/4.0 This is an open access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 4.0) License. See: http://creativecommons.org/licenses/by-nc/4.0/.
spellingShingle Clinical Practice
Johnson, Sara W.
Henderson, Sean
Genetics of Warfarin Sensitivity in an Emergency Department Population with Thromboembolic
title Genetics of Warfarin Sensitivity in an Emergency Department Population with Thromboembolic
title_full Genetics of Warfarin Sensitivity in an Emergency Department Population with Thromboembolic
title_fullStr Genetics of Warfarin Sensitivity in an Emergency Department Population with Thromboembolic
title_full_unstemmed Genetics of Warfarin Sensitivity in an Emergency Department Population with Thromboembolic
title_short Genetics of Warfarin Sensitivity in an Emergency Department Population with Thromboembolic
title_sort genetics of warfarin sensitivity in an emergency department population with thromboembolic
topic Clinical Practice
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3088368/
https://www.ncbi.nlm.nih.gov/pubmed/21691466
work_keys_str_mv AT johnsonsaraw geneticsofwarfarinsensitivityinanemergencydepartmentpopulationwiththromboembolic
AT hendersonsean geneticsofwarfarinsensitivityinanemergencydepartmentpopulationwiththromboembolic